Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0001562180-18-002166

Options or other derivatives

  • President, Diagnostics & Genom acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kelderman Kim · President, Diagnostics & Genom

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2018-05-01 Grant or award : show line 1 in the form Restricted Stock +5,000 5,000 D
2018-05-01 Grant or award : show line 2 in the form Stock Option (Right to Buy) +2,652 2,652 D
2018-05-01 Grant or award : show line 3 in the form Stock Option (Right to Buy) +7,348 10,000 D
Loading xslF345X03/primarydocument.xml…